Northwest Bioth Cmn (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,508 | -5,752 | -12,804 | -10,940 | -12,779 |
| Depreciation Amortization | 1,691 | 249 | 593 | 1,148 | 5,587 |
| Accounts receivable | -3 | -5 | 89 | -17 | 31 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | N/A | 69 |
| Other Working Capital | 1,709 | 415 | -664 | 487 | 568 |
| Other Operating Activity | 686 | 416 | -339 | 380 | 160 |
| Operating Cash Flow | $-4,425 | $-4,677 | $-13,125 | $-8,942 | $-6,364 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,828 | 172 | N/A | N/A |
| PPE Investments | 41 | -54 | -531 | -438 | -2,106 |
| Purchase Sale Intangibles | N/A | 816 | 1,000 | N/A | N/A |
| Other Investing Activity | 120 | 771 | 895 | 0 | 0 |
| Investing Cash Flow | $161 | $2,545 | $536 | $-438 | $-2,106 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,350 | 335 | N/A | N/A | 6,714 |
| Debt Repayment | -93 | -67 | -70 | -1,709 | -38 |
| Common Stock Issued | N/A | N/A | 232 | 17,356 | 1 |
| Other Financing Activity | 0 | -420 | 0 | 8,289 | 1,554 |
| Financing Cash Flow | $4,257 | $-152 | $162 | $23,936 | $8,231 |
| Beginning Cash Position | 255 | 2,539 | 14,966 | 411 | 649 |
| End Cash Position | 248 | 255 | 2,539 | 14,966 | 411 |
| Net Cash Flow | $-7 | $-2,284 | $-12,427 | $14,556 | $-238 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,425 | -4,677 | -13,125 | -8,942 | -6,364 |
| Capital Expenditure | N/A | -149 | -531 | -438 | -2,106 |
| Free Cash Flow | -4,425 | -4,826 | -13,656 | -9,380 | -8,470 |